Abstract
Global prevalence of type 2 diabetes mellitus in children is rising recently, likely due to an increasing rate of childhood obesity. In Taiwan, an annual program of mass screen for diabetes with two-staged design, i.e. diagnosis by fasting plasma glucose when glycosuria was positive in two consecutive urine samples, has been conducted since 1992 for all schoolchildren aged 6 to 18. A recent survey showed that the incidence of type 2 diabetes is 6-fold higher than those of type 1 diabetes. The prevalence of diabetes is elevated during puberty and is higher in girls than in boys. Obesity is the most important risk factor of type 2 diabetes in childhood and adolescence. Besides, genetics, family history, polycystic ovarian syndrome, ethnicity, and puberty are also risk factors of pediatric diabetes. We also briefly discuss the current state of management of obesity and type 2 diabetes, with special emphasis on behavioral and lifestyle modification, the need to create adequate and safe environment, and the psychological as well as family support in children and adolescents. Limited experience of the pharmacological agents in terms of their long-term effect and safety is also discussed.
Keywords: Childhood, Diabetes mellitus, Obesity, Mass screening, Taiwan
Current Diabetes Reviews
Title: Type 2 Diabetes and Obesity in Children and Adolescents: Experience from Studies in Taiwanese Population
Volume: 2 Issue: 2
Author(s): Ling-Yin Chang, Hung-Yuan Li, Jung-Nan Wei and Lee-Ming Chuang
Affiliation:
Keywords: Childhood, Diabetes mellitus, Obesity, Mass screening, Taiwan
Abstract: Global prevalence of type 2 diabetes mellitus in children is rising recently, likely due to an increasing rate of childhood obesity. In Taiwan, an annual program of mass screen for diabetes with two-staged design, i.e. diagnosis by fasting plasma glucose when glycosuria was positive in two consecutive urine samples, has been conducted since 1992 for all schoolchildren aged 6 to 18. A recent survey showed that the incidence of type 2 diabetes is 6-fold higher than those of type 1 diabetes. The prevalence of diabetes is elevated during puberty and is higher in girls than in boys. Obesity is the most important risk factor of type 2 diabetes in childhood and adolescence. Besides, genetics, family history, polycystic ovarian syndrome, ethnicity, and puberty are also risk factors of pediatric diabetes. We also briefly discuss the current state of management of obesity and type 2 diabetes, with special emphasis on behavioral and lifestyle modification, the need to create adequate and safe environment, and the psychological as well as family support in children and adolescents. Limited experience of the pharmacological agents in terms of their long-term effect and safety is also discussed.
Export Options
About this article
Cite this article as:
Chang Ling-Yin, Li Hung-Yuan, Wei Jung-Nan and Chuang Lee-Ming, Type 2 Diabetes and Obesity in Children and Adolescents: Experience from Studies in Taiwanese Population, Current Diabetes Reviews 2006; 2(2) . https://dx.doi.org/10.2174/157339906776818578
DOI https://dx.doi.org/10.2174/157339906776818578 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antioxidant Therapy for Prevention of Inflammation, Ischemic Reperfusion Injuries and Allograft Rejection
Cardiovascular & Hematological Agents in Medicinal Chemistry 25 Hydroxyvitamin D Levels are Negatively and Independently Associated with Fat Mass in a Cohort of Healthy Overweight and Obese Subjects
Endocrine, Metabolic & Immune Disorders - Drug Targets Association of PAF and its Metabolic Enzymes with GGT and the Fatty Liver Index in Healthy Volunteers
Current Vascular Pharmacology Effect of Systemic Inflammation on the Function of Insulin and Glucose Metabolism in Rheumatoid Arthritis
Current Diabetes Reviews Biochemical Strategies to Anticoagulation: A Comparative Overview
Current Vascular Pharmacology Influences of Maternal Nutritional Status on Vascular Function in the Offspring
Current Drug Targets Comparison of Amniotic Fluid Index and Single Deepest Vertical Pocket
Current Women`s Health Reviews Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors
Current Pharmaceutical Design Oxidative Stress in the Pathogenesis/Treatment of Atherosclerosis
Current Nutrition & Food Science Evidence on the Protective Role of High-Density Lipoprotein (HDL) in HIV-Infected Individuals
Current Vascular Pharmacology New Approaches in Drug Delivery Systems: Application for Diabetes Treatment
Infectious Disorders - Drug Targets Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions
Current Vascular Pharmacology The Glomerular Podocyte as a Target of Growth Hormone Action: Implications for the Pathogenesis of Diabetic Nephropathy
Current Diabetes Reviews Essential Fatty Acids - A Review
Current Pharmaceutical Biotechnology Pharmacogenetics Strategies: From Candidate Genes to Whole-Genome Association Analysis. Exploratory or Confirmatory Studies?
Current Pharmacogenomics and Personalized Medicine Age-Related Changes and Effects of Mild Hypothermia on Carotid Artery Reactivity in Newborn Rats
CNS & Neurological Disorders - Drug Targets Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients
Current Vascular Pharmacology Small Molecules as Potent Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors Documented in Patents from 2009 to 2013
Mini-Reviews in Medicinal Chemistry Metabolic Syndrome: Clinical Features Leading to Therapeutic Strategies
Vascular Disease Prevention (Discontinued) Cardio-protective Effects of Glucagon-like Peptide-1 Receptor Agonists: An Overview of Systematic Reviews and Publication Overlap
Current Pharmaceutical Design